Recombinant hepatitis B vaccine (Yuanda Weixin)

重组乙型肝炎疫苗（汉逊酵母，远大赛威信）

Report date: 2024/07/08 14:15:35

Base Information

Drug NameRecombinant hepatitis B vaccine (Yuanda Weixin)

Drug Alias NameN/A

ClassificationVaccines > National Immunization Program > Immunization program vaccine(Class I)Vaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Genetically engineered subunit vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsHepatitis B

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesYuanda Weixin Life Science (Nanjing) Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesYuanda Weixin Life Science (Nanjing) Co Ltd

Inactive CompaniesN/A

Active IndicationsHepatitis B

Inactive IndicationsN/A

Other Information

ATC CodeN/A